Rare diseases are typically caused by genetic mutations that prevent normal bodily functions and are often difficult to diagnose due to the small number of individuals affected by them. Genetic testing for rare diseases can be pre-symptomatic, meaning it can detect the mutation before symptoms appear, or it can be diagnostic, used to confirm a clinical diagnosis. The process of rare disease genetic testing often involves the collection of a blood, saliva, or tissue sample, which is then analyzed using specialized laboratory techniques such as DNA sequencing, chromosomal microarray analysis, and other genetic testing methods. These tests can help identify genetic changes that may be associated with the specific rare disease. Rare disease genetic testing can also provide information on a person’s carrier status, which indicates whether they carry a mutation for a rare disease but do not show any symptoms. This information can be useful for family planning purposes, helping individuals understand the risk of passing on a rare disease to their children. According to the latest market study results, the global rare disease genetic testing market stood at around USD 918.0 百万で 2022 そして米ドル相当にまで上昇すると予測されています 1,727.2 百万までに 2029 終わり, これにより、CAGR が向上します。 9.45% その間 2023-2029.

レポートは市場規模と成長をカバーしています, セグメンテーション, 地域内訳, 競争環境, trends and strategies for global rare disease genetic testing market. 利害関係者が現在の市場機会を活用できるように、市場の定量的な分析を提供します。. このレポートはまた、市場動向と主要な競合他社のアプローチに基づいて、機会と戦略の上位セグメントを特定します。.

この業界レポートは、世界市場の市場推定と予測を提供します。, followed by a detailed analysis of the disease type, テクノロジー, specialty, エンドユーザー, と地域. The global market for rare disease genetic testing can be segmented by disease type: immunological disorders, cardiovascular disorders, neurology disease, endocrine and metabolism disorders diseases, hematology diseases, dermatology disease, その他. The neurology disease segment held the largest share of the global rare disease genetic testing market in 2022 予測期間中もそのシェアを維持すると予想されます. Rare disease genetic testing market is further segmented by technology: next generation sequencing, sanger sequencing, PCR based testing, array based testing, FISH, その他. 世界的に, the next generation sequencing segment made up the largest share of the rare disease genetic testing market. Based on specialty, the rare disease genetic testing market is segmented into: molecular genetic tests, chromosomal genetic tests, biochemical genetic tests. The molecular genetic tests segment was the largest contributor to the global rare disease genetic testing market in 2022. エンドユーザーベース, the rare disease genetic testing market also can be divided into: 病院 & クリニック, 研究室 & CRO, 診断研究所, その他. The research laboratories & CROs segment is estimated to account for the largest share of the global rare disease genetic testing market. Rare disease genetic testing market by region is categorized into: 北米, ヨーロッパ, アジア太平洋地域, もの (中東とアフリカ), ラテンアメリカ.

市場セグメンテーション
By disease type: immunological disorders, cardiovascular disorders, neurology disease, endocrine and metabolism disorders diseases, hematology diseases, dermatology disease, その他
テクノロジー別: next generation sequencing, sanger sequencing, PCR based testing, array based testing, FISH, その他
By specialty: molecular genetic tests, chromosomal genetic tests, biochemical genetic tests
エンドユーザー別: 病院 & クリニック, 研究室 & CRO, 診断研究所, その他
地域別: 北米, ヨーロッパ, アジア太平洋地域, もの (中東とアフリカ), ラテンアメリカ

The global rare disease genetic testing market report offers detailed information on several market vendors, including Associated Regional and University Pathologists, 株式会社, Centogene NV, Eurofins Scientific SE, Fulgent Genetics Inc., OPKO Health, 株式会社, パーキンエルマー株式会社, Quest Diagnostics Incorporated, とりわけ. このレポートでは, 市場の競争見通しを理解するために、主要なプレーヤーとその戦略を徹底的に分析します。.
*無料サンプルをリクエストして企業の完全なリストを入手してください

報告書の範囲
• To analyze and forecast the market size of the global rare disease genetic testing market.
• To classify and forecast the global rare disease genetic testing market based on disease type, テクノロジー, specialty, エンドユーザー, 領域.
• To identify drivers and challenges for the global rare disease genetic testing market.
• 合併などの競争展開を検討するため & 買収, 協定, コラボレーションとパートナーシップ, 等, in the global rare disease genetic testing market.
• To identify and analyze the profile of leading players operating in the global rare disease genetic testing market.

このレポートを選択する理由
• Gain a reliable outlook of the global rare disease genetic testing market forecasts from 2023 に 2029 シナリオ全体にわたって.
• 投資対象となる成長セグメントを特定する.
• 会社概要と市場データを通じて競合他社に先んじる.
• Excel 形式でのシナリオ全体の分析を容易にするための市場予測.
• 3ヶ月間の戦略コンサルティングとリサーチサポート.
• シングルユーザーライセンスに提供される印刷認証.